Propriétés pharmacologiques de la vortioxetine et leurs conséquences pré-cliniquesPharmacological properties of vortioxetine and its pre-clinical consequences
Références (86)
- et al.
Antidépresseurs. Historique
EMC-Psychiatrie
(2004) - et al.
Modeling treatment-resistant depression
Neuropharmacology
(2011) Serotonin receptors involved in antidepressant effects
Pharmacology & therapeutics
(2013)- et al.
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants
Neuron
(2010) - et al.
Role of glutamate and advantages of combining memantine with a 5HT6 ligand in a model of depression
Pharmacological reports
(2014) - et al.
Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease
Life sciences
(2009) - et al.
In vitro effects of the multimodal antidepressant Lu AA21004 at human and rat 5-HT1A, 5-HT1B, 5-HT3 and 5-HT7 receptors, and 5-HT transporters
Eur Neuropsychopharmacol
(2012) - et al.
Differentiating antidepressants of the future: efficacy and safety
Pharmacology & therapeutics
(2007) - et al.
Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters–a rat microdialysis and electrophysiology study
Eur Neuropsychopharmacol
(2013) - et al.
The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain
Brain Res
(2003)
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig
European journal of pharmacology
(2004)
A subpopulation of serotonin 1B receptors colocalize with the AMPA receptor subunit GluR2 in the hippocampal dentate gyrus
Neuroscience letters
(2010)
Dendritic colocalisation of serotonin1B receptors and the glutamate NMDA receptor subunit NR1 within the hippocampal dentate gyrus: an ultrastructural study
Journal of chemical neuroanatomy
(2008)
Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential
Trends in pharmacological sciences
(1993)
Functional, molecular and pharmacological advances in 5-HT7 receptor research
Trends in pharmacological sciences
(2004)
Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H] SB-269970
Neuroscience letters
(2004)
In vivo effect of 5-HT (7) receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study
Neuroscience
(2011)
5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons
Brain research
(2003)
Effect of a 5-HT (1A) receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats
Brain research
(2000)
Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
Pharmacology, biochemistry, and behavior
(2013)
Comparative analysis of the anxiety-related behaviors in four inbred mice
Behavioural processes
(2002)
Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice
Neuropharmacology
(2013)
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression
Neuron
(2009)
Animal models of depression and anxiety: What do they tell us about human condition ?
Progress in neuro-psychopharmacology & biological psychiatry
(2011)
Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats
Behavioural brain research
(2013)
Adult hippocampal neurogenesis: an actor in the antidepressant-like action
Annales pharmaceutiques francaises
(2013)
Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition
Eur Neuropsychopharmacol
(2012)
LTP mechanisms: from silence to four-lane traffic
Current opinion in neurobiology
(2000)
A review of brain oscillations in cognitive disorders and the role of neurotransmitters
Brain research
(2008)
Involvement of 5-HT (7) receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents
Neuropharmacology
(2015)
Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation
Eur Neuropsychopharmacol
(2014)
Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism
Eur Neuropsychopharmacol
(2014)
Memory impairment in old mice is differentially sensitive to different classes of antidepressants
Eur Neuropsychopharmacol
(2013)
Cognitive impairment in major depression
European journal of pharmacology
(2010)
Cognitive dysfunction in unipolar depression: implications for treatment
Journal of affective disorders
(2014)
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Pharmacology & therapeutics
(2006)
Psychiatry and the oldest old
The American journal of psychiatry
(2000)
Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications
American heart journal
(1982)
Pharmacology of antidepressants: selectivity or multiplicity ?
The Journal of clinical psychiatry
(1999)
Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure
Journal of clinical psychopharmacology
(1987)
Comorbidity of mood and anxiety disorders
Depression and anxiety
(2000)
The 5-HT1B receptor: a novel target for the pathophysiology of depression
Current drug targets
(2009)
Cited by (0)
Copyright © 2016 Elsevier Ltd. All rights reserved.